Menstrual Migraine clinical trials

Explore recruiting menstrual migraine clinical trials.

Recruiting menstrual migraine studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Menstrual Migraine trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study with an Open-Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Preventive Treatment of Menstrual Migraine​ ​

Portugal, Poland, Italy, Hungary, Czechia, Germany +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

C4951063: An interventional efficacy and safety, Phase 3, double-blind, parallel group study to investigate intermittent prevention of Menstrual Migraine with Rimegepant compared with placebo in women participants 18 to 45 years of age

Netherlands, Italy, Poland, Denmark, Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

(WHAT!) – RCT: Open-label randomized controlled trial for the effects of continuous daily use of ethinylestradiol/levonorgestrel (30/150 µg/day) compared with vitamin E (400 IU/day) in the treatment of menstrually-related migraine and perimenopausal migraine

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Oxytocine and migraine

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Menstrual Migraine trials by city

Menstrual Migraine in Toronto Menstrual Migraine in Vancouver Menstrual Migraine in Montreal Menstrual Migraine in Calgary Menstrual Migraine in Edmonton Menstrual Migraine in Ottawa Menstrual Migraine in Winnipeg Menstrual Migraine in Quebec City Menstrual Migraine in Hamilton Menstrual Migraine in Kitchener Menstrual Migraine in London Menstrual Migraine in Halifax Menstrual Migraine in New York Menstrual Migraine in Los Angeles Menstrual Migraine in Chicago Menstrual Migraine in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease